文献速递重症综合管理与镇静镇痛

评估ABCDE集束化治疗的成本效益:集束化治疗依从性对住院和1年死亡率及医疗费用的影响

Evaluating the Cost-Effectiveness of the ABCDE Bundle: Impact of Bundle Adherence on Inpatient and 1-Year Mortality and Costs of Care.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论高ABCDE集束化治疗依从性(≥60%)与住院死亡率降低(OR 0.28)相关,且每挽救一个生命增量成本效益比为15,077美元,每获得一个QALY为42,120美元,提示该集束化治疗可能具有成本效益。

这项为期2年的前瞻性成本效益研究纳入6家医院12个成人ICU中2,953例年龄≥18岁、ICU停留>24小时且机械通气>24小时但<14天的患者,评估ABCDE集束化治疗依从性对住院和1年死亡率、质量调整生命年、住院时间和医疗费用的影响。采用倾向评分调整回归模型和Markov模型分析。结果显示高依从性(≥60%)与住院死亡率显著降低(OR 0.28)相关,但住院费用显著增加3,920美元;每挽救一个生命的增量成本效益比为15,077美元(95%CI 13,675-16,479),每获得一个QALY为42,120美元。结论认为ABCDE集束化治疗似乎是降低ICU患者住院和1年死亡率的成本效益手段。

要点

  • 高ABCDE集束化治疗依从性(≥60%)与住院死亡率显著降低相关(OR 0.28)。
  • 高依从性组住院费用显著增加3,920美元,但每挽救一个生命的增量成本效益比为15,077美元(95%CI 13,675-16,479)。
  • 高依从性还与1年费用增加4,949美元和QALY增加0.12相关,每QALY增量成本效益比为42,120美元。
  • 研究纳入机械通气>24小时且<14天的成人ICU患者,提示该集束化治疗可能适用于此类人群。
  • ABCDE集束化治疗似乎是降低住院和1年死亡率的成本效益手段。

适用人群与场景

  • 年龄18岁或以上,ICU停留时间大于24小时,且机械通气时间大于24小时但小于14天的患者。
  • 研究在6家医院的12个成人ICU进行,包括内科/外科、创伤、神经和心脏监护病房。

诊断标准与关键阈值

  • 高ABCDE集束化治疗依从性定义为≥60%。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为为期2年的前瞻性成本效益研究,纳入2,953例患者,在6家医院的12个成人ICU进行。
  • 高ABCDE集束化治疗依从性(≥60%)与住院死亡率显著降低相关(OR 0.28)。
  • 高依从性组住院费用显著增加3,920美元。
  • 每挽救一个生命的增量成本效益比为15,077美元(95%CI 13,675-16,479),每挽救一个生命年的增量成本效益比为1,057美元。
  • 高依从性与QALY增加0.12、1年费用增加4,949美元相关,每QALY的增量成本效益比为42,120美元。

证据类型、等级与局限

  • 证据类型为前瞻性成本效益研究,采用倾向评分调整回归模型和Markov模型。
  • 原文未述局限性。

对床旁实践的改变

  • 对于ICU停留>24小时且机械通气>24小时但<14天的成人患者,提高ABCDE集束化治疗依从性至≥60%可能与住院死亡率降低相关,但需考虑住院费用增加。
  • 该研究提示ABCDE集束化治疗可能是具有成本效益的降低住院和1年死亡率的手段。

指南或共识出处

  • Crit Care Med

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Growing evidence supports the Awakening and Breathing Coordination, Delirium monitoring/management, and Early exercise/mobility (ABCDE) bundle processes as improving a number of short- and long-term clinical outcomes for patients requiring ICU care. To assess the cost-effectiveness of this intervention, we determined the impact of ABCDE bundle adherence on inpatient and 1-year mortality, quality-adjusted life-years, length of stay, and costs of care.

DESIGN: We conducted a 2-year, prospective, cost-effectiveness study in 12 adult ICUs in six hospitals belonging to a large, integrated healthcare delivery system.

SETTING: Hospitals included a large, urban tertiary referral center and five community hospitals. ICUs included medical/surgical, trauma, neurologic, and cardiac care units.

PATIENTS: The study included 2,953 patients, 18 years old or older, with an ICU stay greater than 24 hours, who were on a ventilator for more than 24 hours and less than 14 days.

INTERVENTION: ABCDE bundle.

MEASUREMENTS AND MAIN RESULTS: We used propensity score-adjusted regression models to determine the impact of high bundle adherence on inpatient mortality, discharge status, length of stay, and costs. A Markov model was used to estimate the potential effect of improved bundle adherence on healthcare costs and quality-adjusted life-years in the year following ICU admission. We found that patients with high ABCDE bundle adherence (≥ 60%) had significantly decreased odds of inpatient mortality (odds ratio 0.28) and significantly higher costs ($3,920) of inpatient care. The incremental cost-effectiveness ratio of high bundle adherence was $15,077 (95% CI, $13,675-$16,479) per life saved and $1,057 per life-year saved. High bundle adherence was associated with a 0.12 increase in quality-adjusted life-years, a $4,949 increase in 1-year care costs, and an incremental cost-effectiveness ratio of $42,120 per quality-adjusted life-year.

CONCLUSIONS: The ABCDE bundle appears to be a cost-effective means to reduce in-hospital and 1-year mortality for patients with an ICU stay.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Collinsworth AW, Priest EL, Masica AL, et al. Evaluating the Cost-Effectiveness of the ABCDE Bundle: Impact of Bundle Adherence on Inpatient and 1-Year Mortality and Costs of Care. Crit Care Med. 2020. PMID: 33003078. doi:10.1097/CCM.0000000000004609

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。